Clinical Trial Update: Safety and Tolerability Of Allogeneic Mesenchymal Stromal Cells in Pediatric Inflammatory Bowel Disease [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of allogeneic mesenchymal stromal cells in pediatric inflammatory bowel disease. Results posted January 20,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Allogeneic Mesenchymal Stromal Cells (mesenchymal stromal cells)

Snippet

Sponsor: Catherine Bollard | Conditions: Inflammatory Bowel Diseases | Phase 1 | Status: COMPLETED | Results posted: 2023-01-20